| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.851 | 0.001 | 0.851 | GABA C receptor rho-3 antagonist | 0.794 0.002 DBMET00831 0.794 0.002 DB14028 0.716 0.003 DB00231 0.668 0.004 DBMET00246 0.284 0.127 DBMET01219 | ||
| 0.823 | 0.004 | 0.89 | Anticonvulsant | 0.805 0.004 DBMET00831 0.805 0.004 DB14028 0.89 0.004 DB00231 0.878 0.004 DBMET00246 | DB00231 | |
| 0.677 | 0.002 | 0.677 | GABA C receptor rho-2 antagonist | 0.572 0.002 DBMET00831 0.572 0.002 DB14028 0.373 0.004 DB00231 0.344 0.004 DBMET00246 0.151 0.072 DBMET01219 | ||
| 0.673 | 0.002 | 0.754 | Benzodiazepine agonist | 0.601 0.002 DBMET00831 0.601 0.002 DB14028 0.754 0.002 DB00231 0.667 0.002 DBMET00246 | DB00231 | |
| 0.675 | 0.005 | 0.823 | Psychostimulant | 0.574 0.007 DBMET00831 0.574 0.007 DB14028 0.823 0.004 DB00231 0.568 0.007 DBMET00246 0.377 0.026 DBMET01219 | DB00231 | |
| 0.664 | 0.003 | 0.703 | GABA A receptor antagonist | 0.651 0.003 DBMET00831 0.651 0.003 DB14028 0.703 0.003 DB00231 0.699 0.003 DBMET00246 | DB00231 | |
| 0.662 | 0.003 | 0.706 | GABA receptor antagonist | 0.66 0.003 DBMET00831 0.66 0.003 DB14028 0.699 0.003 DB00231 0.706 0.003 DBMET00246 | DBMET00246 | |
| 0.646 | 0.004 | 0.646 | Sigma receptor agonist | 0.529 0.007 DBMET00831 0.529 0.007 DB14028 | ||
| 0.563 | 0.005 | 0.615 | Anesthetic general | 0.345 0.025 DBMET00831 0.345 0.025 DB14028 0.615 0.004 DB00231 0.577 0.005 DBMET00246 0.315 0.03 DBMET01219 | DB00231 | |
| 0.559 | 0.004 | 0.703 | GABA receptor agonist | 0.482 0.004 DBMET00831 0.482 0.004 DB14028 0.703 0.003 DB00231 0.637 0.003 DBMET00246 | DB00231 | |
| 0.516 | 0.006 | 0.516 | Cyclic AMP phosphodiesterase inhibitor | 0.514 0.006 DBMET00831 0.514 0.006 DB14028 0.233 0.073 DB00231 0.226 0.077 DBMET00246 0.35 0.026 DBMET01219 | ||
| 0.474 | 0.011 | 0.474 | Interleukin agonist | 0.354 0.028 DBMET00831 0.354 0.028 DB14028 0.245 0.083 DB00231 0.195 0.126 DBMET00246 0.406 0.018 DBMET01219 | ||
| 0.379 | 0.004 | 0.469 | GABA C receptor antagonist | 0.469 0.003 DBMET00831 0.469 0.003 DB14028 0.169 0.021 DB00231 0.218 0.01 DBMET00246 | DB14028 | |
| 0.377 | 0.003 | 0.377 | GABA C receptor rho-1 antagonist | 0.321 0.003 DBMET00831 0.321 0.003 DB14028 0.187 0.01 DB00231 0.191 0.01 DBMET00246 | ||
| 0.378 | 0.006 | 0.378 | Gastrin inhibitor | 0.334 0.015 DBMET00831 0.334 0.015 DB14028 0.284 0.045 DB00231 0.23 0.104 DBMET00246 0.199 0.15 DBMET01219 | ||
| 0.351 | 0.007 | 0.494 | Glutamate receptor antagonist | 0.494 0.004 DBMET00831 0.494 0.004 DB14028 0.174 0.036 DBMET00246 | DB14028 | |
| 0.312 | 0.002 | 0.312 | Benzodiazepine antagonist | 0.185 0.003 DBMET00831 0.185 0.003 DB14028 0.109 0.004 DB00231 0.133 0.003 DBMET00246 | ||
| 0.327 | 0.029 | 0.417 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.417 0.014 DBMET00831 0.417 0.014 DB14028 0.267 0.045 DB00231 0.322 0.03 DBMET00246 | DB14028 | |
| 0.29 | 0.005 | 0.322 | Glutamate (mGluR) antagonist | 0.322 0.005 DBMET00831 0.322 0.005 DB14028 | DB14028 | |
| 0.263 | 0.006 | 0.263 | Falcipain 2 inhibitor | 0.244 0.008 DBMET00831 0.244 0.008 DB14028 0.085 0.064 DBMET01219 | ||
| 0.26 | 0.007 | 0.26 | Falcipain inhibitor | 0.243 0.008 DBMET00831 0.243 0.008 DB14028 0.087 0.066 DBMET01219 | ||
| 0.31 | 0.058 | 0.365 | Aryl hydrocarbon receptor agonist | 0.365 0.045 DBMET00831 0.365 0.045 DB14028 0.22 0.092 DB00231 0.264 0.073 DBMET00246 | DB14028 | |
| 0.26 | 0.011 | 0.291 | ATPase inhibitor | 0.248 0.014 DBMET00831 0.248 0.014 DB14028 0.184 0.053 DB00231 0.202 0.036 DBMET00246 0.291 0.007 DBMET01219 | DBMET01219 | |
| 0.308 | 0.067 | 0.354 | 5 Hydroxytryptamine release stimulant | 0.354 0.055 DBMET00831 0.354 0.055 DB14028 0.164 0.161 DB00231 0.181 0.139 DBMET00246 0.258 0.085 DBMET01219 | DB14028 | |
| 0.246 | 0.005 | 0.322 | Glutamate (mGluR group I) antagonist | 0.322 0.005 DBMET00831 0.322 0.005 DB14028 | DB14028 | |
| 0.264 | 0.042 | 0.274 | RNA-directed DNA polymerase inhibitor | 0.274 0.038 DBMET00831 0.274 0.038 DB14028 0.215 0.079 DB00231 0.25 0.049 DBMET00246 0.235 0.059 DBMET01219 | DB14028 | |
| 0.225 | 0.008 | 0.225 | Interleukin 8 antagonist | 0.201 0.012 DBMET00831 0.201 0.012 DB14028 0.204 0.012 DB00231 0.218 0.009 DBMET00246 0.099 0.098 DBMET01219 | ||
| 0.219 | 0.004 | 0.219 | Phosphodiesterase II inhibitor | 0.188 0.005 DBMET00831 0.188 0.005 DB14028 | ||
| 0.217 | 0.008 | 0.217 | GABA A receptor agonist | 0.113 0.028 DBMET00831 0.113 0.028 DB14028 | ||
| 0.284 | 0.077 | 0.458 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.326 0.048 DBMET00831 0.326 0.048 DB14028 0.421 0.017 DB00231 0.458 0.012 DBMET00246 | DBMET00246 | |
| 0.234 | 0.03 | 0.234 | Polo-like kinase-3 inhibitor | 0.161 0.073 DBMET00831 0.161 0.073 DB14028 0.141 0.095 DB00231 | ||
| 0.208 | 0.004 | 0.208 | Phosphodiesterase 2A inhibitor | 0.176 0.005 DBMET00831 0.176 0.005 DB14028 | ||
| 0.352 | 0.149 | 0.464 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.464 0.052 DBMET00831 0.464 0.052 DB14028 0.38 0.119 DBMET00246 | DB14028 | |
| 0.203 | 0.003 | 0.203 | GABA B receptor antagonist | 0.147 0.004 DBMET00831 0.147 0.004 DB14028 0.05 0.019 DB00231 0.053 0.017 DBMET00246 | ||
| 0.263 | 0.069 | 0.263 | 5 Hydroxytryptamine uptake stimulant | 0.244 0.087 DBMET00831 0.244 0.087 DB14028 0.206 0.14 DB00231 0.192 0.168 DBMET00246 | ||
| 0.199 | 0.004 | 0.203 | Glutamate (mGluR5) antagonist | 0.203 0.004 DBMET00831 0.203 0.004 DB14028 | DB14028 | |
| 0.215 | 0.024 | 0.215 | Sodium channel (voltage-gated) blocker | 0.183 0.036 DBMET00831 0.183 0.036 DB14028 | ||
| 0.204 | 0.014 | 0.22 | 5 Hydroxytryptamine 3A agonist | 0.22 0.01 DBMET00831 0.22 0.01 DB14028 0.101 0.074 DB00231 0.116 0.059 DBMET00246 | DB14028 | |
| 0.183 | 0.004 | 0.183 | Bromodomain-containing protein 2 inhibitor | 0.175 0.005 DBMET00831 0.175 0.005 DB14028 0.133 0.016 DB00231 0.103 0.037 DBMET00246 | ||
| 0.301 | 0.141 | 0.301 | Analgesic | 0.257 0.176 DBMET00831 0.257 0.176 DB14028 0.265 0.169 DB00231 0.233 0.199 DBMET00246 | ||
| 0.244 | 0.094 | 0.244 | Spasmolytic | 0.183 0.134 DBMET00831 0.183 0.134 DB14028 | ||
| 0.235 | 0.092 | 0.235 | 5 Hydroxytryptamine 1E antagonist | 0.234 0.093 DBMET00831 0.234 0.093 DB14028 | ||
| 0.212 | 0.073 | 0.337 | Platelet aggregation inhibitor | 0.337 0.028 DBMET00831 0.337 0.028 DB14028 | DB14028 | |
| 0.16 | 0.026 | 0.216 | Protein kinase C gamma inhibitor | 0.141 0.037 DBMET00831 0.141 0.037 DB14028 0.216 0.011 DB00231 0.192 0.016 DBMET00246 | DB00231 | |
| 0.165 | 0.035 | 0.176 | Cystathionine beta-synthase inhibitor | 0.101 0.075 DBMET00831 0.101 0.075 DB14028 0.176 0.031 DB00231 0.108 0.068 DBMET00246 | DB00231 | |
| 0.172 | 0.044 | 0.172 | Sodium channel blocker | 0.143 0.063 DBMET00831 0.143 0.063 DB14028 | ||
| 0.132 | 0.005 | 0.248 | Cholecystokinin antagonist | 0.089 0.01 DBMET00831 0.089 0.01 DB14028 0.248 0.004 DB00231 0.116 0.007 DBMET00246 | DB00231 | |
| 0.161 | 0.036 | 0.161 | Pregnane X receptor agonist | 0.152 0.049 DBMET00831 0.152 0.049 DB14028 0.132 0.094 DB00231 | ||
| 0.243 | 0.127 | 0.364 | Interleukin 2 agonist | 0.364 0.039 DBMET01219 | DBMET01219 | |
| 0.169 | 0.055 | 0.169 | Thiol protease inhibitor | 0.167 0.056 DBMET00831 0.167 0.056 DB14028 | ||
| 0.172 | 0.059 | 0.173 | Cyclin-dependent kinase 8 inhibitor | 0.173 0.057 DBMET00831 0.173 0.057 DB14028 | DB14028 | |
| 0.14 | 0.032 | 0.14 | Sphingosine 1-phosphate receptor 2 agonist | 0.133 0.039 DBMET00831 0.133 0.039 DB14028 0.11 0.075 DB00231 0.104 0.09 DBMET00246 | ||
| 0.131 | 0.025 | 0.131 | Polo-like kinase-1 inhibitor | 0.09 0.062 DBMET00831 0.09 0.062 DB14028 | ||
| 0.132 | 0.026 | 0.201 | Protein kinase C zeta inhibitor | 0.124 0.03 DBMET00831 0.124 0.03 DB14028 0.201 0.011 DB00231 0.186 0.013 DBMET00246 | DB00231 | |
| 0.112 | 0.007 | 0.112 | Cholecystokinin A antagonist | 0.097 0.009 DBMET00831 0.097 0.009 DB14028 0.039 0.024 DB00231 | ||
| 0.198 | 0.094 | 0.198 | Potassium channel blocker | |||
| 0.108 | 0.004 | 0.108 | Delayed rectifier potassium channel blocker | 0.044 0.016 DB00231 | ||
| 0.107 | 0.004 | 0.355 | Purinergic P2X4 antagonist | 0.355 0.002 DBMET00831 0.355 0.002 DB14028 0.048 0.027 DB00231 0.079 0.007 DBMET00246 | DB14028 | |
| 0.104 | 0.005 | 0.104 | MAP kinase 7 inhibitor | 0.092 0.016 DB00231 | ||
| 0.109 | 0.011 | 0.109 | Bromodomain-containing protein 4 inhibitor | 0.049 0.048 DBMET00831 0.049 0.048 DB14028 | ||
| 0.102 | 0.006 | 0.109 | Corticotropin releasing factor 2 receptor antagonist | 0.109 0.005 DBMET00831 0.109 0.005 DB14028 0.059 0.049 DB00231 | DB14028 | |
| 0.116 | 0.023 | 0.116 | Cannabinoid receptor antagonist | 0.094 0.031 DBMET00831 0.094 0.031 DB14028 | ||
| 0.114 | 0.021 | 0.159 | Glycine receptor antagonist | 0.156 0.006 DBMET00831 0.156 0.006 DB14028 0.104 0.029 DB00231 0.146 0.008 DBMET00246 0.159 0.006 DBMET01219 | DBMET01219 | |
| 0.148 | 0.056 | 0.148 | NADPH oxidase inhibitor | 0.121 0.082 DBMET00831 0.121 0.082 DB14028 | ||
| 0.099 | 0.007 | 0.123 | MDM2 inhibitor | 0.123 0.004 DBMET00831 0.123 0.004 DB14028 0.078 0.022 DB00231 0.087 0.013 DBMET00246 | DB14028 | |
| 0.121 | 0.032 | 0.283 | Potassium channel activator | 0.161 0.016 DBMET00831 0.161 0.016 DB14028 0.227 0.006 DB00231 0.283 0.005 DBMET00246 | DBMET00246 | |
| 0.126 | 0.037 | 0.126 | Creatine kinase inhibitor | 0.117 0.043 DBMET00831 0.117 0.043 DB14028 0.114 0.045 DB00231 0.106 0.053 DBMET00246 | ||
| 0.124 | 0.035 | 0.166 | DNA directed RNA polymerase inhibitor | 0.166 0.02 DBMET00831 0.166 0.02 DB14028 | DB14028 | |
| 0.097 | 0.012 | 0.097 | Glutamate (mGluR7) antagonist | 0.08 0.027 DB00231 | ||
| 0.13 | 0.047 | 0.142 | Ferrochelatase inhibitor | 0.142 0.041 DBMET00831 0.142 0.041 DB14028 0.091 0.081 DB00231 0.099 0.072 DBMET00246 | DB14028 | |
| 0.085 | 0.004 | 0.234 | Benzodiazepine receptor peripheral-type antagonist | 0.079 0.004 DBMET00831 0.079 0.004 DB14028 0.106 0.003 DB00231 0.234 0.002 DBMET00246 | DBMET00246 | |
| 0.102 | 0.022 | 0.102 | 5 Hydroxytryptamine 1D antagonist | |||
| 0.122 | 0.045 | 0.122 | Acetylcholine release stimulant | |||
| 0.213 | 0.142 | 0.213 | Nootropic | |||
| 0.09 | 0.02 | 0.094 | Cannabinoid CB1 receptor antagonist | 0.094 0.019 DBMET00831 0.094 0.019 DB14028 | DB14028 | |
| 0.147 | 0.08 | 0.147 | Diuretic | 0.14 0.086 DBMET00831 0.14 0.086 DB14028 0.129 0.095 DBMET01219 | ||
| 0.077 | 0.01 | 0.077 | Bromodomain-containing protein 3 inhibitor | 0.066 0.015 DBMET00831 0.066 0.015 DB14028 0.059 0.022 DB00231 0.048 0.037 DBMET00246 | ||
| 0.135 | 0.069 | 0.16 | Phosphodiesterase inhibitor | 0.16 0.052 DBMET00831 0.16 0.052 DB14028 | DB14028 | |
| 0.087 | 0.021 | 0.087 | 5 Hydroxytryptamine 3 antagonist | |||
| 0.095 | 0.03 | 0.095 | Polo-like kinase-2 inhibitor | 0.066 0.057 DB00231 | ||
| 0.083 | 0.022 | 0.083 | 5 Hydroxytryptamine 5A antagonist | 0.062 0.041 DBMET00831 0.062 0.041 DB14028 | ||
| 0.08 | 0.018 | 0.08 | Cyclin D1 inhibitor | 0.074 0.023 DBMET00831 0.074 0.023 DB14028 0.062 0.04 DB00231 0.056 0.05 DBMET00246 | ||
| 0.123 | 0.062 | 0.182 | Platelet activating factor antagonist | 0.182 0.031 DBMET00831 0.182 0.031 DB14028 | DB14028 | |
| 0.115 | 0.054 | 0.115 | Interleukin 2 antagonist | |||
| 0.118 | 0.058 | 0.21 | Polo-like kinase-4 inhibitor | 0.21 0.014 DBMET00831 0.21 0.014 DB14028 | DB14028 | |
| 0.118 | 0.059 | 0.211 | DNA intercalator | 0.093 0.081 DBMET00831 0.093 0.081 DB14028 0.211 0.023 DBMET01219 | DBMET01219 | |
| 0.177 | 0.12 | 0.226 | ErbB-1 antagonist | 0.226 0.066 DBMET00831 0.226 0.066 DB14028 0.175 0.124 DBMET00246 | DB14028 | |
| 0.086 | 0.03 | 0.086 | Nav1.7 sodium channel blocker | 0.071 0.043 DBMET00831 0.071 0.043 DB14028 | ||
| 0.146 | 0.091 | 0.146 | Heat shock protein 90 alpha antagonist | |||
| 0.076 | 0.022 | 0.076 | 5 Hydroxytryptamine 5 antagonist | 0.057 0.041 DBMET00831 0.057 0.041 DB14028 | ||
| 0.105 | 0.051 | 0.155 | Electrolyte absorption antagonist | 0.111 0.044 DBMET00831 0.111 0.044 DB14028 0.146 0.021 DB00231 0.155 0.018 DBMET00246 | DBMET00246 | |
| 0.152 | 0.101 | 0.165 | Catenin beta inhibitor | 0.165 0.074 DBMET00831 0.165 0.074 DB14028 0.147 0.114 DBMET00246 | DB14028 | |
| 0.07 | 0.019 | 0.086 | 5 Hydroxytryptamine 7 agonist | 0.086 0.01 DBMET00831 0.086 0.01 DB14028 | DB14028 | |
| 0.081 | 0.03 | 0.081 | 5 Hydroxytryptamine 3A antagonist | |||
| 0.204 | 0.154 | 0.229 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.229 0.097 DBMET00831 0.229 0.097 DB14028 0.204 0.155 DBMET00246 | DB14028 | |
| 0.08 | 0.03 | 0.094 | Protein kinase C beta inhibitor | 0.075 0.038 DBMET00831 0.075 0.038 DB14028 0.094 0.017 DB00231 0.088 0.021 DBMET00246 | DB00231 | |
| 0.077 | 0.028 | 0.081 | Phosphodiesterase VII inhibitor | 0.081 0.025 DBMET00831 0.081 0.025 DB14028 | DB14028 | |
| 0.127 | 0.08 | 0.127 | Toll-Like receptor 9 antagonist | |||
| 0.064 | 0.018 | 0.064 | Farnesyltransferase inhibitor | |||
| 0.069 | 0.024 | 0.069 | Cannabinoid CB2 receptor antagonist | |||
| 0.082 | 0.037 | 0.082 | Vanilloid 4 agonist | 0.07 0.066 DBMET00831 0.07 0.066 DB14028 | ||
| 0.07 | 0.026 | 0.07 | Potassium channel intermediate-conductance Ca-activated blocker | 0.061 0.04 DBMET00831 0.061 0.04 DB14028 | ||
| 0.1 | 0.056 | 0.166 | Potassium channel (Ca-activated) activator | 0.166 0.023 DBMET00831 0.166 0.023 DB14028 0.096 0.059 DBMET00246 | DB14028 | |
| 0.059 | 0.015 | 0.075 | Benzodiazepine inverse agonist | 0.075 0.008 DBMET00831 0.075 0.008 DB14028 0.049 0.027 DBMET00246 | DB14028 | |
| 0.073 | 0.032 | 0.073 | 5 Hydroxytryptamine 3 agonist | 0.063 0.044 DBMET00831 0.063 0.044 DB14028 | ||
| 0.088 | 0.049 | 0.088 | Histamine H1 receptor antagonist | |||
| 0.165 | 0.127 | 0.199 | Aldehyde oxidase inhibitor | 0.199 0.105 DBMET00831 0.199 0.105 DB14028 0.161 0.129 DBMET00246 | DB14028 | |
| 0.176 | 0.138 | 0.305 | DNA damaging | 0.191 0.123 DBMET00831 0.191 0.123 DB14028 0.219 0.101 DB00231 0.212 0.106 DBMET00246 0.305 0.055 DBMET01219 | DBMET01219 | |
| 0.109 | 0.072 | 0.109 | 5 Hydroxytryptamine antagonist | |||
| 0.149 | 0.112 | 0.278 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.278 0.049 DBMET00831 0.278 0.049 DB14028 0.161 0.102 DBMET00246 | DB14028 | |
| 0.22 | 0.184 | 0.352 | Calcium channel activator | 0.352 0.048 DBMET00831 0.352 0.048 DB14028 | DB14028 | |
| 0.051 | 0.016 | 0.058 | Acid-sensing ion channel blocker | 0.058 0.01 DBMET00831 0.058 0.01 DB14028 0.042 0.025 DBMET00246 | DB14028 | |
| 0.065 | 0.03 | 0.073 | Phosphodiesterase 1A inhibitor | 0.073 0.021 DBMET00831 0.073 0.021 DB14028 | DB14028 | |
| 0.049 | 0.015 | 0.049 | 5 Hydroxytryptamine 3B antagonist | |||
| 0.134 | 0.1 | 0.134 | Ca2+-transporting ATPase inhibitor | 0.131 0.112 DBMET00831 0.131 0.112 DB14028 0.132 0.111 DB00231 0.129 0.124 DBMET00246 0.13 0.118 DBMET01219 | ||
| 0.084 | 0.051 | 0.084 | Caspase 7 inhibitor | 0.076 0.072 DB00231 | ||
| 0.058 | 0.026 | 0.103 | AMPA receptor antagonist | 0.103 0.011 DBMET00831 0.103 0.011 DB14028 0.078 0.018 DBMET00246 | DB14028 | |
| 0.069 | 0.037 | 0.127 | NMDA receptor glycine site agonist | 0.127 0.007 DBMET00831 0.127 0.007 DB14028 0.108 0.013 DBMET00246 | DB14028 | |
| 0.044 | 0.012 | 0.196 | Cholecystokinin B antagonist | 0.196 0.004 DB00231 0.061 0.008 DBMET00246 | DB00231 | |
| 0.078 | 0.046 | 0.082 | Adenosine A3 receptor antagonist | 0.082 0.04 DBMET00831 0.082 0.04 DB14028 | DB14028 | |
| 0.073 | 0.043 | 0.197 | Cyclin B3 inhibitor | 0.154 0.013 DBMET00831 0.154 0.013 DB14028 0.139 0.016 DB00231 0.197 0.006 DBMET00246 | DBMET00246 | |
| 0.145 | 0.115 | 0.166 | Neurotensin receptor agonist | 0.166 0.068 DBMET00831 0.166 0.068 DB14028 0.142 0.122 DBMET00246 | DB14028 | |
| 0.049 | 0.019 | 0.049 | Nerve growth factor antagonist | |||
| 0.055 | 0.027 | 0.055 | Purinergic P2X antagonist | 0.055 0.027 DBMET00831 0.055 0.027 DB14028 | ||
| 0.187 | 0.16 | 0.221 | Tyrosine 3 hydroxylase inhibitor | 0.221 0.102 DBMET00831 0.221 0.102 DB14028 0.188 0.159 DBMET00246 | DB14028 | |
| 0.093 | 0.066 | 0.111 | Lanosterol 14 alpha demethylase inhibitor | 0.111 0.04 DBMET00831 0.111 0.04 DB14028 0.096 0.062 DBMET00246 | DB14028 | |
| 0.056 | 0.031 | 0.063 | Nicotinic alpha3beta2 receptor antagonist | 0.063 0.023 DBMET00831 0.063 0.023 DB14028 | DB14028 | |
| 0.052 | 0.028 | 0.052 | Histamine H4 receptor antagonist | 0.051 0.029 DBMET00831 0.051 0.029 DB14028 | ||
| 0.145 | 0.121 | 0.158 | Non-steroidal antiinflammatory agent | 0.158 0.106 DBMET01219 | DBMET01219 | |
| 0.049 | 0.026 | 0.049 | Secretase gamma inhibitor | |||
| 0.038 | 0.015 | 0.038 | Adenosine uptake inhibitor | |||
| 0.234 | 0.211 | 0.297 | MAP kinase kinase 6 inhibitor | 0.297 0.138 DBMET00831 0.297 0.138 DB14028 0.226 0.225 DBMET00246 | DB14028 | |
| 0.041 | 0.019 | 0.053 | p53 inhibitor | 0.053 0.012 DBMET00831 0.053 0.012 DB14028 | DB14028 | |
| 0.082 | 0.06 | 0.082 | 5 Hydroxytryptamine 2C antagonist | |||
| 0.045 | 0.024 | 0.056 | Alpha 1L adrenoreceptor agonist | 0.056 0.011 DBMET00831 0.056 0.011 DB14028 0.041 0.036 DBMET00246 | DB14028 | |
| 0.064 | 0.043 | 0.064 | Kallikrein 7 inhibitor | 0.064 0.043 DB00231 0.063 0.046 DBMET00246 | ||
| 0.029 | 0.009 | 0.029 | Geranylgeranyltransferase inhibitor | |||
| 0.081 | 0.061 | 0.091 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.091 0.048 DBMET00831 0.091 0.048 DB14028 0.082 0.061 DBMET00246 | DB14028 | |
| 0.143 | 0.123 | 0.254 | Death-associated protein kinase 2 inhibitor | 0.254 0.012 DBMET00831 0.254 0.012 DB14028 0.148 0.11 DB00231 0.246 0.014 DBMET00246 | DB14028 | |
| 0.041 | 0.022 | 0.041 | CF transmembrane conductance regulator antagonist | 0.041 0.023 DB00231 | ||
| 0.065 | 0.045 | 0.065 | 5 Hydroxytryptamine 1B antagonist | |||
| 0.153 | 0.134 | 0.153 | Potassium channel (Voltage-sensitive) blocker | |||
| 0.144 | 0.126 | 0.214 | MAP kinase kinase 2 inhibitor | 0.214 0.073 DBMET00831 0.214 0.073 DB14028 | DB14028 | |
| 0.057 | 0.04 | 0.057 | 5 Hydroxytryptamine 6 antagonist | 0.051 0.048 DBMET00831 0.051 0.048 DB14028 | ||
| 0.06 | 0.043 | 0.06 | TRPA1 antagonist | |||
| 0.059 | 0.043 | 0.059 | Potassium channel (Ca-activated) blocker | 0.058 0.046 DBMET00831 0.058 0.046 DB14028 | ||
| 0.133 | 0.118 | 0.203 | LIM domain kinase 1 inhibitor | 0.203 0.061 DBMET00831 0.203 0.061 DB14028 | DB14028 | |
| 0.166 | 0.151 | 0.201 | 5 Hydroxytryptamine 3E antagonist | 0.201 0.061 DBMET00831 0.201 0.061 DB14028 | DB14028 | |
| 0.106 | 0.091 | 0.106 | Transcription factor STAT6 inhibitor | |||
| 0.076 | 0.062 | 0.076 | Leucine-rich repeat kinase 2 inhibitor | |||
| 0.064 | 0.05 | 0.064 | Acetylcholine M5 receptor agonist | |||
| 0.109 | 0.097 | 0.117 | Nav1.2 sodium channel blocker | 0.117 0.087 DBMET00831 0.117 0.087 DB14028 | DB14028 | |
| 0.054 | 0.041 | 0.055 | Phosphodiesterase 4C inhibitor | 0.055 0.04 DBMET00831 0.055 0.04 DB14028 | DB14028 | |
| 0.079 | 0.067 | 0.098 | Histamine N-methyltransferase inhibitor | 0.098 0.048 DBMET00831 0.098 0.048 DB14028 | DB14028 | |
| 0.08 | 0.068 | 0.08 | T cell inhibitor | |||
| 0.045 | 0.034 | 0.056 | Adenylate cyclase 1 inhibitor | 0.056 0.02 DBMET00831 0.056 0.02 DB14028 | DB14028 | |
| 0.06 | 0.049 | 0.06 | Phosphodiesterase 1C inhibitor | 0.06 0.048 DBMET00831 0.06 0.048 DB14028 | ||
| 0.04 | 0.03 | 0.04 | Liver X receptor alpha agonist | |||
| 0.072 | 0.062 | 0.113 | GABA B receptor agonist | 0.113 0.009 DBMET00831 0.113 0.009 DB14028 0.097 0.019 DBMET00246 | DB14028 | |
| 0.042 | 0.033 | 0.126 | NMDA receptor subunit 3B antagonist | 0.126 0.008 DBMET00831 0.126 0.008 DB14028 0.049 0.026 DBMET00246 | DB14028 | |
| 0.051 | 0.042 | 0.109 | Protein kinase C eta inhibitor | 0.109 0.015 DB00231 0.082 0.023 DBMET00246 | DB00231 | |
| 0.082 | 0.075 | 0.11 | HIV-1 integrase (Overall Integration) inhibitor | 0.11 0.046 DBMET00831 0.11 0.046 DB14028 | DB14028 | |
| 0.114 | 0.107 | 0.149 | Cytidine deaminase inhibitor | 0.149 0.076 DB00231 | DB00231 | |
| 0.036 | 0.029 | 0.08 | NMDA receptor subunit 3A antagonist | 0.08 0.012 DBMET00831 0.08 0.012 DB14028 | DB14028 | |
| 0.061 | 0.054 | 0.061 | Calcium channel P-type blocker | |||
| 0.128 | 0.122 | 0.165 | MAP kinase kinase 4 inhibitor | 0.165 0.038 DBMET00831 0.165 0.038 DB14028 0.158 0.048 DBMET00246 | DB14028 | |
| 0.057 | 0.051 | 0.062 | Purinergic P2 antagonist | 0.062 0.046 DBMET00831 0.062 0.046 DB14028 | DB14028 | |
| 0.052 | 0.047 | 0.052 | Dopamine D4 antagonist | |||
| 0.011 | 0.007 | 0.011 | CD80 antagonist | 0.011 0.008 DBMET00831 0.011 0.008 DB14028 | ||
| 0.029 | 0.025 | 0.029 | Potassium channel small-conductance Ca-activated activator | 0.028 0.025 DBMET00831 0.028 0.025 DB14028 | ||
| 0.009 | 0.006 | 0.009 | Corticotropin releasing factor antagonist | |||
| 0.047 | 0.044 | 0.047 | 5 Hydroxytryptamine 4 antagonist | |||
| 0.053 | 0.05 | 0.059 | Pregnane X receptor antagonist | 0.059 0.033 DBMET00831 0.059 0.033 DB14028 | DB14028 | |
| 0.083 | 0.08 | 0.086 | Glutamate release inhibitor | 0.086 0.071 DBMET00831 0.086 0.071 DB14028 | DB14028 | |
| 0.063 | 0.061 | 0.063 | 5 Hydroxytryptamine 1 antagonist | |||
| 0.242 | 0.24 | 0.419 | 5 Hydroxytryptamine release inhibitor | 0.419 0.067 DBMET00831 0.419 0.067 DB14028 0.358 0.108 DBMET00246 0.348 0.117 DBMET01219 | DB14028 | |
| 0.114 | 0.112 | 0.114 | Mannose-6-phosphate isomerase inhibitor | |||
| 0.03 | 0.029 | 0.031 | Estrogen-related receptor beta antagonist | 0.031 0.026 DB00231 | DB00231 | |
| 0.054 | 0.054 | 0.082 | 5 Hydroxytryptamine 2A agonist | 0.082 0.026 DBMET00831 0.082 0.026 DB14028 | DB14028 | |
| 0.078 | 0.08 | 0.095 | Phosphodiesterase I inhibitor | 0.095 0.051 DBMET00831 0.095 0.051 DB14028 | DB14028 | |
| 0.065 | 0.066 | 0.097 | Phospholipase D inhibitor | 0.097 0.016 DBMET00831 0.097 0.016 DB14028 0.066 0.063 DBMET00246 | DB14028 | |
| 0.052 | 0.055 | 0.062 | Phosphodiesterase 1B inhibitor | 0.062 0.04 DBMET00831 0.062 0.04 DB14028 | DB14028 | |
| 0.083 | 0.087 | 0.205 | Topoisomerase I inhibitor | 0.205 0.025 DBMET01219 | DBMET01219 | |
| 0.076 | 0.081 | 0.081 | D-Ala-D-Ala ligase inhibitor | 0.078 0.074 DBMET00831 0.078 0.074 DB14028 0.078 0.073 DB00231 0.081 0.067 DBMET00246 | DBMET00246 | |
| 0.024 | 0.028 | 0.03 | Toll-Like receptor 4 agonist | 0.03 0.012 DBMET01219 | DBMET01219 | |
| 0.091 | 0.095 | 0.101 | 5 Hydroxytryptamine 2B antagonist | 0.101 0.082 DBMET00831 0.101 0.082 DB14028 | DB14028 | |
| 0.034 | 0.04 | 0.053 | 5 Hydroxytryptamine 2B agonist | 0.053 0.012 DBMET00831 0.053 0.012 DB14028 | DB14028 | |
| 0.03 | 0.035 | 0.033 | Protein kinase (CK2) beta inhibitor | 0.033 0.023 DBMET00831 0.033 0.023 DB14028 | DB14028 | |
| 0.042 | 0.048 | 0.055 | 5 Hydroxytryptamine 2 agonist | 0.055 0.032 DBMET00831 0.055 0.032 DB14028 | DB14028 | |
| 0.08 | 0.088 | 0.094 | MAP kinase kinase 1 inhibitor | 0.086 0.076 DBMET00831 0.086 0.076 DB14028 0.094 0.064 DB00231 | DB00231 | |
| 0.025 | 0.036 | 0.073 | Kainate receptor 2 antagonist | 0.073 0.008 DBMET00831 0.073 0.008 DB14028 0.047 0.018 DBMET00246 | DB14028 | |
| 0.045 | 0.056 | 0.125 | Glutamate (mGluR1) antagonist | 0.125 0.01 DBMET00831 0.125 0.01 DB14028 | DB14028 | |
| 0.054 | 0.067 | 0.076 | Aryl hydrocarbon receptor antagonist | 0.076 0.031 DBMET00831 0.076 0.031 DB14028 | DB14028 | |
| 0.037 | 0.051 | 0.047 | Histamine H1 receptor agonist | 0.047 0.023 DBMET00831 0.047 0.023 DB14028 | DB14028 | |
| 0.016 | 0.03 | 0.065 | NMDA receptor glycine site antagonist | 0.065 0.005 DBMET00831 0.065 0.005 DB14028 0.041 0.008 DBMET00246 | DB14028 | |
| 0.039 | 0.054 | 0.046 | Parathyroid hormone antagonist | 0.046 0.028 DBMET00831 0.046 0.028 DB14028 | DB14028 | |
| 0.051 | 0.065 | 0.11 | NMDA receptor agonist | 0.11 0.016 DBMET00831 0.11 0.016 DB14028 0.087 0.025 DBMET00246 | DB14028 | |
| 0.029 | 0.044 | 0.031 | Protein kinase C beta I inhibitor | 0.031 0.03 DB00231 | DB00231 | |
| 0.103 | 0.118 | 0.146 | DNA repair enzyme inhibitor | 0.146 0.036 DBMET01219 | DBMET01219 | |
| 0.032 | 0.048 | 0.13 | Phosphorylase inhibitor | 0.062 0.024 DBMET00831 0.062 0.024 DB14028 0.051 0.03 DB00231 0.066 0.022 DBMET00246 0.13 0.009 DBMET01219 | DBMET01219 | |
| 0.174 | 0.191 | 0.345 | Cholesterol antagonist | 0.345 0.066 DBMET01219 | DBMET01219 | |
| 0.118 | 0.14 | 0.167 | MAP kinase 3 inhibitor | 0.145 0.075 DBMET00831 0.145 0.075 DB14028 0.137 0.091 DB00231 0.167 0.046 DBMET00246 | DBMET00246 | |
| 0.105 | 0.127 | 0.198 | Cell wall synthesis inhibitor | 0.143 0.072 DB00231 0.126 0.091 DBMET00246 0.198 0.03 DBMET01219 | DBMET01219 | |
| 0.016 | 0.039 | 0.038 | Cyclin E2 inhibitor | 0.028 0.021 DBMET00831 0.028 0.021 DB14028 0.038 0.013 DBMET00246 | DBMET00246 | |
| 0.109 | 0.132 | 0.284 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.151 0.088 DBMET00831 0.151 0.088 DB14028 0.221 0.055 DB00231 0.284 0.037 DBMET00246 | DBMET00246 | |
| 0.065 | 0.089 | 0.183 | NMDA receptor antagonist | 0.183 0.017 DBMET00831 0.183 0.017 DB14028 0.118 0.036 DBMET00246 | DB14028 | |
| 0.058 | 0.082 | 0.065 | Exportin-1 inhibitor | 0.065 0.055 DBMET00831 0.065 0.055 DB14028 | DB14028 | |
| 0.099 | 0.124 | 0.134 | Sphingosine 1-phosphate receptor 4 antagonist | 0.134 0.051 DBMET00831 0.134 0.051 DB14028 | DB14028 | |
| 0.136 | 0.161 | 0.178 | Neurotrophic factor enhancer | 0.178 0.101 DBMET00831 0.178 0.101 DB14028 | DB14028 | |
| 0.087 | 0.112 | 0.108 | MAP kinase kinase inhibitor | 0.108 0.086 DBMET00831 0.108 0.086 DB14028 | DB14028 | |
| 0.014 | 0.04 | 0.026 | Calcitonin gene-related peptide antagonist | 0.026 0.017 DB00231 | DB00231 | |
| 0.03 | 0.057 | 0.044 | AMPA 4 receptor antagonist | 0.044 0.021 DBMET00831 0.044 0.021 DB14028 0.036 0.034 DBMET00246 | DB14028 | |
| 0.125 | 0.153 | 0.151 | 3C-like protease (Human coronavirus) inhibitor | 0.151 0.1 DBMET00831 0.151 0.1 DB14028 | DB14028 | |
| 0.061 | 0.089 | 0.105 | Phosphodiesterase 3A inhibitor | 0.105 0.029 DBMET00831 0.105 0.029 DB14028 | DB14028 | |
| 0.034 | 0.063 | 0.059 | Adenosine A2b receptor antagonist | 0.059 0.025 DBMET00831 0.059 0.025 DB14028 | DB14028 | |
| 0.088 | 0.117 | 0.1 | Photosensitizer | 0.098 0.093 DBMET00831 0.098 0.093 DB14028 0.1 0.088 DBMET01219 | DBMET01219 | |
| 0.052 | 0.082 | 0.084 | Potassium channel large-conductance Ca-activated activator | 0.084 0.032 DBMET00831 0.084 0.032 DB14028 0.061 0.058 DBMET00246 | DB14028 | |
| 0.054 | 0.088 | 0.086 | Protein kinase B beta inhibitor | 0.078 0.044 DBMET00831 0.078 0.044 DB14028 0.086 0.036 DBMET00246 | DBMET00246 | |
| 0.087 | 0.121 | 0.216 | Glycogen synthase kinase-3 alpha inhibitor | 0.216 0.037 DBMET00831 0.216 0.037 DB14028 | DB14028 | |
| 0.09 | 0.125 | 0.137 | Cytokine production inhibitor | 0.137 0.073 DBMET00831 0.137 0.073 DB14028 | DB14028 | |
| 0.127 | 0.163 | 0.151 | Succinate dehydrogenase inhibitor | 0.151 0.111 DBMET00831 0.151 0.111 DB14028 0.151 0.11 DBMET00246 | DBMET00246 | |
| 0.181 | 0.217 | 0.34 | Immunosuppressant | 0.34 0.092 DBMET01219 | DBMET01219 | |
| 0.012 | 0.05 | 0.024 | Kainate receptor 4 antagonist | 0.024 0.018 DBMET00831 0.024 0.018 DB14028 | DB14028 | |
| 0.037 | 0.077 | 0.056 | Pim-2 kinase inhibitor | 0.056 0.035 DBMET00831 0.056 0.035 DB14028 | DB14028 | |
| 0.148 | 0.188 | 0.252 | MAP-kinase-activated kinase 5 inhibitor | 0.192 0.114 DBMET00831 0.192 0.114 DB14028 0.207 0.095 DB00231 0.252 0.058 DBMET00246 | DBMET00246 | |
| 0.025 | 0.067 | 0.06 | Factor XIa inhibitor | 0.06 0.013 DBMET00831 0.06 0.013 DB14028 | DB14028 | |
| 0.018 | 0.061 | 0.025 | Thymidine phosphorylase inhibitor | 0.025 0.021 DBMET00831 0.025 0.021 DB14028 0.024 0.023 DBMET00246 | DB14028 | |
| 0.046 | 0.089 | 0.084 | Prostaglandin-E synthase inhibitor | 0.084 0.036 DBMET00831 0.084 0.036 DB14028 | DB14028 | |
| 0.019 | 0.067 | 0.081 | Kainate receptor antagonist | 0.052 0.02 DBMET00831 0.052 0.02 DB14028 0.081 0.01 DBMET00246 | DBMET00246 | |
| 0.066 | 0.115 | 0.164 | NADH dehydrogenase inhibitor | 0.082 0.071 DBMET00831 0.082 0.071 DB14028 0.094 0.051 DBMET00246 0.164 0.015 DBMET01219 | DBMET01219 | |
| 0.024 | 0.074 | 0.138 | Phosphodiesterase 3B inhibitor | 0.138 0.006 DBMET00831 0.138 0.006 DB14028 | DB14028 | |
| 0.064 | 0.117 | 0.089 | Pim-3 kinase inhibitor | 0.089 0.059 DBMET00831 0.089 0.059 DB14028 | DB14028 | |
| 0.065 | 0.119 | 0.121 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.094 0.06 DBMET00831 0.094 0.06 DB14028 0.112 0.044 DBMET00246 0.121 0.039 DBMET01219 | DBMET01219 | |
| 0.048 | 0.103 | 0.067 | I kappa B kinase 1 inhibitor | 0.067 0.053 DBMET00831 0.067 0.053 DB14028 | DB14028 | |
| 0.066 | 0.121 | 0.08 | mTOR complex 2 inhibitor | 0.08 0.069 DBMET00831 0.08 0.069 DB14028 | DB14028 | |
| 0.063 | 0.12 | 0.085 | MAP kinase kinase 7 inhibitor | 0.085 0.035 DBMET00831 0.085 0.035 DB14028 0.078 0.053 DBMET00246 | DB14028 | |
| 0.177 | 0.234 | 0.342 | Histamine release inhibitor | 0.238 0.164 DBMET00831 0.238 0.164 DB14028 0.342 0.104 DBMET01219 | DBMET01219 | |
| 0.069 | 0.126 | 0.11 | Alpha 2b adrenoreceptor antagonist | 0.11 0.066 DBMET00831 0.11 0.066 DB14028 | DB14028 | |
| 0.1 | 0.159 | 0.141 | Aurora-C kinase inhibitor | 0.141 0.062 DBMET00831 0.141 0.062 DB14028 0.122 0.1 DBMET00246 | DB14028 | |
| 0.076 | 0.135 | 0.119 | MAP kinase 12 inhibitor | 0.119 0.072 DBMET00831 0.119 0.072 DB14028 0.109 0.084 DBMET00246 | DB14028 | |
| 0.049 | 0.108 | 0.072 | Protein kinase B gamma inhibitor | 0.072 0.055 DBMET00831 0.072 0.055 DB14028 | DB14028 | |
| 0.005 | 0.064 | 0.022 | Kainate receptor 1 antagonist | 0.022 0.014 DBMET00831 0.022 0.014 DB14028 | DB14028 | |
| 0.068 | 0.129 | 0.155 | Topoisomerase II inhibitor | 0.155 0.047 DBMET01219 | DBMET01219 | |
| 0.086 | 0.148 | 0.111 | CDC-like kinase 1 inhibitor | 0.111 0.106 DBMET00831 0.111 0.106 DB14028 | DB14028 | |
| 0.006 | 0.068 | 0.032 | AMPA 1 receptor antagonist | 0.032 0.019 DBMET00831 0.032 0.019 DB14028 | DB14028 | |
| 0.035 | 0.098 | 0.136 | Phosphodiesterase III inhibitor | 0.136 0.012 DBMET00831 0.136 0.012 DB14028 | DB14028 | |
| 0.069 | 0.133 | 0.106 | Nav1.1 sodium channel blocker | 0.106 0.059 DB00231 0.097 0.07 DBMET00246 | DB00231 | |
| 0.106 | 0.171 | 0.123 | Sphingosine 1-phosphate receptor 5 antagonist | 0.123 0.118 DBMET00831 0.123 0.118 DB14028 | DB14028 | |
| 0.019 | 0.084 | 0.045 | Factor XI inhibitor | 0.045 0.012 DBMET00831 0.045 0.012 DB14028 0.037 0.019 DBMET00246 | DB14028 | |
| 0.164 | 0.229 | 0.455 | Antithrombotic | 0.455 0.037 DBMET01219 | DBMET01219 | |
| 0.069 | 0.138 | 0.106 | MAP kinase 13 inhibitor | 0.106 0.072 DBMET00831 0.106 0.072 DB14028 0.098 0.084 DBMET00246 | DB14028 | |
| 0.119 | 0.189 | 0.369 | Immunostimulant | 0.369 0.059 DBMET01219 | DBMET01219 | |
| 0.15 | 0.229 | 0.185 | Neuropeptide Y2 antagonist | 0.185 0.149 DBMET00831 0.185 0.149 DB14028 | DB14028 | |
| 0.064 | 0.146 | 0.133 | EphA2 antagonist | 0.133 0.042 DBMET00831 0.133 0.042 DB14028 | DB14028 | |
| 0.093 | 0.176 | 0.13 | MAP3K9 inhibitor | 0.13 0.094 DBMET00831 0.13 0.094 DB14028 0.126 0.102 DBMET00246 | DB14028 | |
| 0.022 | 0.11 | 0.088 | Plasminogen activator inhibitor | 0.067 0.034 DB00231 0.088 0.021 DBMET00246 | DBMET00246 | |
| 0.073 | 0.164 | 0.123 | Ca2+/calmodulin-dependent kinase II delta inhibitor | 0.123 0.082 DBMET00246 | DBMET00246 | |
| 0.209 | 0.307 | 0.352 | Caspase 9 stimulant | 0.263 0.237 DB00231 0.284 0.212 DBMET00246 0.352 0.144 DBMET01219 | DBMET01219 | |
| 0.068 | 0.167 | 0.128 | Nav1.6 sodium channel blocker | 0.128 0.084 DBMET00831 0.128 0.084 DB14028 | DB14028 | |
| 0.141 | 0.242 | 0.236 | Nitric-oxide synthase stimulant | 0.236 0.043 DBMET00831 0.236 0.043 DB14028 0.206 0.079 DBMET00246 0.172 0.147 DBMET01219 | DB14028 | |
| 0.063 | 0.167 | 0.281 | Beta glucuronidase inhibitor | 0.117 0.048 DBMET00831 0.117 0.048 DB14028 0.095 0.078 DB00231 0.165 0.019 DBMET00246 0.281 0.007 DBMET01219 | DBMET01219 | |
| 0.115 | 0.222 | 0.183 | Cyclin-dependent kinase 3 inhibitor | 0.183 0.046 DBMET00831 0.183 0.046 DB14028 0.17 0.06 DBMET00246 | DB14028 | |
| 0.021 | 0.13 | 0.076 | NMDA 2C receptor antagonist | 0.076 0.028 DBMET00831 0.076 0.028 DB14028 | DB14028 | |
| 0.086 | 0.195 | 0.156 | Hexokinase inhibitor | 0.156 0.072 DBMET01219 | DBMET01219 | |
| 0.127 | 0.248 | 0.199 | 12-Lipoxygenase inhibitor | 0.199 0.152 DBMET00831 0.199 0.152 DB14028 | DB14028 | |
| 0.13 | 0.252 | 0.295 | DNA synthesis inhibitor | 0.295 0.045 DBMET01219 | DBMET01219 | |
| 0.027 | 0.149 | 0.079 | Cyclin B1 inhibitor | 0.063 0.039 DBMET00831 0.063 0.039 DB14028 0.079 0.023 DBMET00246 | DBMET00246 | |
| 0.026 | 0.15 | 0.067 | CDC7 inhibitor | 0.067 0.047 DBMET00831 0.067 0.047 DB14028 | DB14028 | |
| 0.021 | 0.145 | 0.079 | Cyclin B2 inhibitor | 0.063 0.028 DBMET00831 0.063 0.028 DB14028 0.079 0.015 DBMET00246 | DBMET00246 | |
| 0.072 | 0.198 | 0.172 | Peroxidase inhibitor | 0.167 0.07 DBMET00831 0.167 0.07 DB14028 0.172 0.068 DBMET00246 | DBMET00246 | |
| 0.014 | 0.14 | 0.049 | NMDA 2A receptor antagonist | 0.049 0.038 DBMET00831 0.049 0.038 DB14028 | DB14028 | |
| 0.074 | 0.201 | 0.223 | Cholinergic | 0.223 0.037 DBMET01219 | DBMET01219 | |
| 0.071 | 0.199 | 0.112 | Interleukin 1 antagonist | 0.112 0.101 DBMET00831 0.112 0.101 DB14028 | DB14028 | |
| 0.074 | 0.205 | 0.136 | Anticoagulant | 0.136 0.093 DBMET01219 | DBMET01219 | |
| 0.016 | 0.148 | 0.039 | CDK5/p25 inhibitor | 0.039 0.031 DBMET00831 0.039 0.031 DB14028 | DB14028 | |
| 0.01 | 0.142 | 0.04 | Sodium/glucose cotransporter inhibitor | 0.04 0.007 DBMET01219 | DBMET01219 | |
| 0.087 | 0.22 | 0.181 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.181 0.105 DBMET00831 0.181 0.105 DB14028 | DB14028 | |
| 0.084 | 0.216 | 0.185 | NOS3 expression enhancer | 0.185 0.047 DBMET01219 | DBMET01219 | |
| 0.033 | 0.171 | 0.101 | Topoisomerase II alpha inhibitor | 0.101 0.039 DBMET01219 | DBMET01219 | |
| 0.139 | 0.28 | 0.23 | Insulysin inhibitor | 0.23 0.116 DBMET00831 0.23 0.116 DB14028 | DB14028 | |
| 0.022 | 0.164 | 0.073 | Cyclin B inhibitor | 0.056 0.036 DBMET00831 0.056 0.036 DB14028 0.073 0.019 DBMET00246 | DBMET00246 | |
| 0.025 | 0.169 | 0.046 | Potassium channel (ATP-sensitive) activator | 0.046 0.038 DBMET00831 0.046 0.038 DB14028 | DB14028 | |
| 0.085 | 0.231 | 0.177 | Dyrk kinase inhibitor | 0.177 0.112 DBMET00831 0.177 0.112 DB14028 | DB14028 | |
| 0.026 | 0.172 | 0.048 | Potassium channel (Inward rectifier) activator | 0.048 0.039 DBMET00831 0.048 0.039 DB14028 | DB14028 | |
| 0.044 | 0.192 | 0.142 | Protein kinase C mu inhibitor | 0.134 0.034 DB00231 0.142 0.03 DBMET00246 | DBMET00246 | |
| 0.048 | 0.209 | 0.106 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | 0.106 0.094 DBMET00831 0.106 0.094 DB14028 | DB14028 | |
| 0.08 | 0.247 | 0.19 | Hemostatic | 0.19 0.037 DBMET01219 | DBMET01219 | |
| 0.044 | 0.212 | 0.151 | UDP-glucose 4-epimerase inhibitor | 0.151 0.028 DBMET01219 | DBMET01219 | |
| 0.054 | 0.222 | 0.235 | Acetylcholinesterase inhibitor | 0.235 0.024 DBMET01219 | DBMET01219 | |
| 0.031 | 0.199 | 0.067 | MAP-kinase-activated kinase 2 inhibitor | 0.067 0.063 DBMET00831 0.067 0.063 DB14028 | DB14028 | |
| 0.007 | 0.177 | 0.031 | Sodium/glucose cotransporter 2 inhibitor | 0.031 0.012 DBMET01219 | DBMET01219 | |
| 0.053 | 0.228 | 0.128 | Alpha-N-acetylglucosaminidase inhibitor | 0.128 0.071 DBMET01219 | DBMET01219 | |
| 0.135 | 0.312 | 0.324 | Apoptosis antagonist | 0.324 0.07 DBMET01219 | DBMET01219 | |
| 0.056 | 0.243 | 0.148 | Cyclooxygenase 3 inhibitor | 0.148 0.05 DBMET01219 | DBMET01219 | |
| 0.035 | 0.223 | 0.074 | MAP-kinase-activated kinase inhibitor | 0.074 0.072 DBMET00831 0.074 0.072 DB14028 | DB14028 | |
| 0.05 | 0.244 | 0.12 | Nav1.4 sodium channel blocker | 0.12 0.052 DBMET00831 0.12 0.052 DB14028 0.094 0.086 DBMET00246 | DB14028 | |
| 0.007 | 0.207 | 0.029 | Histone deacetylase 5 inhibitor | 0.029 0.026 DB00231 | DB00231 | |
| 0.044 | 0.254 | 0.222 | Amylase inhibitor | 0.222 0.037 DBMET01219 | DBMET01219 | |
| 0.041 | 0.257 | 0.08 | Triose-phosphate isomerase inhibitor | 0.08 0.076 DBMET01219 | DBMET01219 | |
| 0.022 | 0.241 | 0.073 | Heparanase inhibitor | 0.073 0.01 DBMET01219 | DBMET01219 | |
| 0.01 | 0.229 | 0.07 | NMDA 2 receptor antagonist | 0.07 0.051 DBMET00831 0.07 0.051 DB14028 | DB14028 | |
| 0.078 | 0.3 | 0.172 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.172 0.116 DBMET00831 0.172 0.116 DB14028 | DB14028 | |
| 0.041 | 0.263 | 0.141 | AMP-activated protein kinase stimulant | 0.141 0.034 DBMET01219 | DBMET01219 | |
| 0.094 | 0.319 | 0.263 | Transcription factor NF kappa B inhibitor | 0.263 0.118 DBMET01219 | DBMET01219 | |
| 0.077 | 0.31 | 0.14 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.14 0.092 DBMET00831 0.14 0.092 DB14028 0.127 0.124 DBMET00246 | DB14028 | |
| 0.035 | 0.268 | 0.06 | Lipocortins synthesis agonist | 0.06 0.036 DBMET01219 | DBMET01219 | |
| 0.024 | 0.285 | 0.052 | Sodium/calcium exchanger inhibitor | 0.052 0.03 DBMET00831 0.052 0.03 DB14028 | DB14028 | |
| 0.03 | 0.296 | 0.102 | ATPase (Vacuolar H+) inhibitor | 0.102 0.037 DBMET01219 | DBMET01219 | |
| 0.058 | 0.329 | 0.142 | Death-associated protein kinase 3 inhibitor | 0.142 0.136 DBMET00831 0.142 0.136 DB14028 | DB14028 | |
| 0.062 | 0.334 | 0.292 | Hepatoprotectant | 0.292 0.032 DBMET01219 | DBMET01219 | |
| 0.03 | 0.308 | 0.103 | Alkylator | 0.103 0.085 DBMET01219 | DBMET01219 | |
| 0.039 | 0.318 | 0.148 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.148 0.122 DBMET00831 0.148 0.122 DB14028 | DB14028 | |
| 0.038 | 0.318 | 0.155 | Protein kinase C nu inhibitor | 0.112 0.103 DB00231 0.155 0.067 DBMET00246 | DBMET00246 | |
| 0.125 | 0.411 | 0.366 | Apoptosis agonist | 0.366 0.131 DBMET01219 | DBMET01219 | |
| 0.044 | 0.333 | 0.101 | Cell adhesion inhibitor | 0.101 0.087 DBMET01219 | DBMET01219 | |
| 0.091 | 0.387 | 0.135 | CC chemokine 6 receptor antagonist | 0.135 0.052 DBMET01219 | DBMET01219 | |
| 0.09 | 0.391 | 0.223 | Immunomodulator | 0.223 0.139 DBMET01219 | DBMET01219 | |
| 0.013 | 0.32 | 0.053 | Alpha-mannosidase inhibitor | 0.053 0.038 DBMET01219 | DBMET01219 | |
| 0.009 | 0.337 | 0.045 | Mannosidase inhibitor | 0.045 0.032 DBMET01219 | DBMET01219 | |
| 0.073 | 0.407 | 0.132 | Death-associated protein kinase 1 inhibitor | 0.132 0.076 DBMET00831 0.132 0.076 DB14028 0.124 0.101 DBMET00246 | DB14028 | |
| 0.085 | 0.434 | 0.526 | Antibacterial | 0.526 0.034 DBMET01219 | DBMET01219 | |
| 0.051 | 0.4 | 0.172 | Interleukin 6 antagonist | 0.134 0.116 DB00231 0.161 0.074 DBMET00246 0.172 0.062 DBMET01219 | DBMET01219 | |
| 0.026 | 0.388 | 0.073 | Chymotrypsin inhibitor | 0.073 0.065 DBMET00246 | DBMET00246 | |
| 0.025 | 0.403 | 0.059 | Adenine nucleotide translocase inhibitor | 0.059 0.03 DBMET01219 | DBMET01219 | |
| 0.108 | 0.507 | 0.332 | Antiinflammatory | 0.332 0.187 DBMET01219 | DBMET01219 | |
| 0.032 | 0.433 | 0.126 | Toll-Like receptor 4 antagonist | 0.126 0.038 DBMET01219 | DBMET01219 | |
| 0.015 | 0.427 | 0.059 | Glucose-6-phosphate translocase inhibitor | 0.059 0.025 DBMET01219 | DBMET01219 | |
| 0.115 | 0.535 | 0.455 | Calcium channel L-type activator | 0.455 0.048 DBMET00831 0.455 0.048 DB14028 0.279 0.175 DBMET00246 | DB14028 | |
| 0.017 | 0.443 | 0.069 | Factor IXa inhibitor | 0.069 0.021 DBMET01219 | DBMET01219 | |
| 0.084 | 0.531 | 0.151 | MAP kinase kinase 5 inhibitor | 0.151 0.147 DBMET00831 0.151 0.147 DB14028 | DB14028 | |
| 0.073 | 0.538 | 0.239 | Caspase 3 stimulant | 0.239 0.122 DBMET01219 | DBMET01219 | |
| 0.005 | 0.484 | 0.157 | Antineoplastic antibiotic | 0.157 0.029 DBMET01219 | DBMET01219 | |
| 0.009 | 0.531 | 0.267 | 5-Lipoxygenase inhibitor | 0.267 0.014 DBMET01219 | DBMET01219 | |
| 0.017 | 0.559 | 0.198 | Thrombolytic | 0.198 0.053 DBMET01219 | DBMET01219 | |
| 0.009 | 0.552 | 0.085 | Protein 50S ribosomal subunit inhibitor | 0.085 0.018 DBMET01219 | DBMET01219 | |
| 0.075 | 0.651 | 0.355 | Peptidyltransferase inhibitor | 0.355 0.011 DBMET01219 | DBMET01219 | |
| 0.005 | 0.656 | 0.267 | Selectin antagonist | 0.267 0.007 DBMET01219 | DBMET01219 | |
| 0.011 | 0.69 | 0.345 | Free radical scavenger | 0.345 0.04 DBMET01219 | DBMET01219 | |
| 0.016 | 0.7 | 0.14 | Insulin secretagoues | 0.14 0.085 DBMET01219 | DBMET01219 | |
| 0.014 | 0.715 | 0.222 | Nitric oxide antagonist | 0.222 0.06 DBMET01219 | DBMET01219 | |
| 0.004 | 0.763 | 0.027 | Protein 30S ribosomal subunit inhibitor | 0.027 0.014 DBMET01219 | DBMET01219 | |
| 0.02 | 0.79 | 0.328 | Hypoglycemic | 0.328 0.043 DBMET01219 | DBMET01219 | |
| 0.015 | 0.79 | 0.236 | Platelet adhesion inhibitor | 0.236 0.054 DBMET01219 | DBMET01219 | |
| 0.01 | 0.788 | 0.442 | Angiogenesis stimulant | 0.442 0.016 DBMET01219 | DBMET01219 | |
| 0.005 | 0.79 | 0.167 | Lipid peroxidase inhibitor | 0.167 0.057 DBMET00246 0.124 0.09 DBMET01219 | DBMET00246 | |
| 0.015 | 0.828 | 0.296 | Cyclophilin D inhibitor | 0.296 0.166 DBMET01219 | DBMET01219 | |
| 0.003 | 0.837 | 0.038 | 1,3-Beta-glucan synthase inhibitor | 0.036 0.005 DB00231 0.038 0.005 DBMET00246 0.031 0.012 DBMET01219 | DBMET00246 | |
| 0.005 | 0.84 | 0.342 | Antioxidant | 0.178 0.134 DBMET00246 0.342 0.048 DBMET01219 | DBMET01219 | |
| 0.006 | 0.885 | 0.06 | Antibiotic Aminoglycoside-like | 0.06 0.009 DBMET01219 | DBMET01219 | |
| 0.013 | 0.971 | 0.093 | Transcription factor NF kappa B stimulant | 0.093 0.047 DBMET01219 | DBMET01219 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |